Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Virchows Archiv : an International Journal of Pathology
|
October 29, 2010
Chromosome 3p alterations in pancreatic endocrine neoplasia
Eliana Amato, Stefano Barbi, Giorgio Malpeli, et al.
American Journal of Clinical Pathology
|
May 16, 2008
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy
Matteo Brunelli, Erminia Manfrin, Guido Martignoni, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 20, 2010
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type
Stefano Barbi, Ivana Cataldo, Giovanni De Manzoni, et al.
Anticancer Research
|
October 4, 2011
FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma
Matteo Brunelli, Diego Segala, Brett Delahunt, et al.
Current Oncology Reports
|
July 16, 2021
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
Claudio Luchini, Rita T Lawlor, Samantha Bersani, et al.
American Journal of Clinical Pathology
|
April 17, 2009
Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria
Matteo Brunelli, Erminia Manfrin, Guido Martignoni, et al.
Histopathology
|
December 16, 2011
Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies
Eleonora Brunello, Matteo Brunelli, Erminia Manfrin, et al.
Journal of Gastrointestinal Cancer
|
September 16, 2024
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature
Paola Mattiolo, Mario De Bellis, Andrea Mafficini, et al.
Neuroendocrinology
|
October 25, 2014
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components
Maria Scardoni, Emanuele Vittoria, Marco Volante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2006
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
Claudia Roldo, Edoardo Missiaglia, John P Hagan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Virchows Archiv : an International Journal of Pathology
|
October 29, 2010
Chromosome 3p alterations in pancreatic endocrine neoplasia
Eliana Amato, Stefano Barbi, Giorgio Malpeli, et al.
American Journal of Clinical Pathology
|
May 16, 2008
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy
Matteo Brunelli, Erminia Manfrin, Guido Martignoni, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 20, 2010
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type
Stefano Barbi, Ivana Cataldo, Giovanni De Manzoni, et al.
Anticancer Research
|
October 4, 2011
FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma
Matteo Brunelli, Diego Segala, Brett Delahunt, et al.
Current Oncology Reports
|
July 16, 2021
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
Claudio Luchini, Rita T Lawlor, Samantha Bersani, et al.
American Journal of Clinical Pathology
|
April 17, 2009
Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria
Matteo Brunelli, Erminia Manfrin, Guido Martignoni, et al.
Histopathology
|
December 16, 2011
Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies
Eleonora Brunello, Matteo Brunelli, Erminia Manfrin, et al.
Journal of Gastrointestinal Cancer
|
September 16, 2024
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature
Paola Mattiolo, Mario De Bellis, Andrea Mafficini, et al.
Neuroendocrinology
|
October 25, 2014
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components
Maria Scardoni, Emanuele Vittoria, Marco Volante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2006
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
Claudia Roldo, Edoardo Missiaglia, John P Hagan, et al.
Page
of 3